King's Invasive Aspergillosis Study II

NCT02875743 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Aplastic Anemia
Leukemia, Myeloid, Acute
Myelodysplastic Syndromes
Bone Marrow Transplantation

Interventions

DRUG: Posaconazole

Sponsor

King's College Hospital NHS Trust